UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Biofluid Biomarkers in Huntington's Disease

Rodrigues, FB; Byrne, LM; Wild, EJ; (2018) Biofluid Biomarkers in Huntington's Disease. In: Precious, SV and Rosser, AE and Dunnett, SB, (eds.) Huntington’s Disease. (pp. 329-396). Humana Press: New York, NY, USA. Green open access

[thumbnail of Rodrigues_07 Wild Fluid Biomarkers sbd svr edits v11.pdf]
Preview
Text
Rodrigues_07 Wild Fluid Biomarkers sbd svr edits v11.pdf - Accepted Version

Download (778kB) | Preview

Abstract

Huntington's disease (HD) is a chronic progressive neurodegenerative condition where new markers of disease progression are needed. So far no disease-modifying interventions have been found, and few interventions have been proven to alleviate symptoms. This may be partially explained by the lack of reliable indicators of disease severity, progression, and phenotype.Biofluid biomarkers may bring advantages in addition to clinical measures, such as reliability, reproducibility, price, accuracy, and direct quantification of pathobiological processes at the molecular level; and in addition to empowering clinical trials, they have the potential to generate useful hypotheses for new drug development.In this chapter we review biofluid biomarker reports in HD, emphasizing those we feel are likely to be closest to clinical applicability.

Type: Book chapter
Title: Biofluid Biomarkers in Huntington's Disease
ISBN-13: 978-1-4939-7824-3
Open access status: An open access version is available from UCL Discovery
DOI: 10.1007/978-1-4939-7825-0_17
Publisher version: https://doi.org/10.1007/978-1-4939-7825-0_17
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Biomarkers, Blood, Cerebrospinal fluid, Huntington’s disease, Review, Urine, Biomarkers, Body Fluids, Brain, Drug Development, Humans, Huntingtin Protein, Huntington Disease, Inflammation Mediators, Neurons, Neurotransmitter Agents, Oxidative Stress, Proteomics, Transglutaminases
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10049810
Downloads since deposit
39,900Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item